C-peptide as a Mediator of Lesion Development in Early Diabetes—A Novel Hypothesis

Al-Rasheed, 2004, Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity, J Biol Chem, 279, 49747, 10.1074/jbc.M408268200 Balletshofer, 2000, Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance, Circulation, 101, 1780, 10.1161/01.CIR.101.15.1780 Balletshofer, 2003, Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness, Atherosclerosis, 171, 303, 10.1016/j.atherosclerosis.2003.08.013 Beckman, 2002, Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570 Burke, 2004, Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study, Arterioscler Thromb Vasc Biol, 24, 1266, 10.1161/01.ATV.0000131783.74034.97 Dandona, 2006, Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes, Rev Cardiovasc Med, 7, S25 Dandona, 2007, Anti-inflammatory effects of insulin, Curr Opin Clin Nutr Metab Care, 10, 511, 10.1097/MCO.0b013e3281e38774 Ekberg, 2007, C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy, Diabetes Care, 30, 71, 10.2337/dc06-1274 Forst, 1998, Microvascular skin blood flow following the ingestion of 75 g glucose in healthy individuals, Exp Clin Endocrinol Diabetes, 106, 454, 10.1055/s-0029-1212015 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430 Henriksson, 2001, Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts, Biochem Biophys Res Commun, 280, 423, 10.1006/bbrc.2000.4135 Johansson, 1992, Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients, Diabetologia, 35, 1151, 10.1007/BF00401369 Johansson, 2004, C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients, Am J Physiol Endocrinol Metab, 286, E14, 10.1152/ajpendo.00236.2003 Johansson, 2003, C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism, Am J Physiol Endocrinol Metab, 285, E864, 10.1152/ajpendo.00001.2003 Johansson, 2002, Molecular effects of proinsulin C-peptide, Biochem Biophys Res Commun, 295, 1035, 10.1016/S0006-291X(02)00721-0 Kamiya, 2006, C-Peptide reverses nociceptive neuropathy in type 1 diabetes, Diabetes, 55, 3581, 10.2337/db06-0396 Kitamura, 2001, Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein, Biochem J, 355, 123, 10.1042/0264-6021:3550123 Kitamura, 2002, Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells, Biochem J, 366, 737, 10.1042/bj20020344 Kobayashi, 2005, Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions, Diabetologia, 48, 2396, 10.1007/s00125-005-1942-9 Libby, 2001, Current concepts of the pathogenesis of the acute coronary syndromes, Circulation, 104, 365, 10.1161/01.CIR.104.3.365 Marx, 2004, C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro, Arterioscl Thromb Vasc Biol, 24, 540, 10.1161/01.ATV.0000116027.81513.68 Ohtomo, 1996, C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y, Diabetologia, 39, 199, 10.1007/BF00403963 Ohtomo, 1998, Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments, Diabetologia, 41, 287, 10.1007/s001250050905 Pramanik, 2001, C-peptide binding to human cell membranes: importance of Glu27, Biochem Biophys Res Commun, 284, 94, 10.1006/bbrc.2001.4917 Rigler, 1999, Specific binding of proinsulin C-peptide to human cell membranes, Proc Natl Acad Sci U S A, 96, 13318, 10.1073/pnas.96.23.13318 Ross, 1999, Atherosclerosis–an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Scalia, 2000, C-peptide inhibits leukocyte–endothelium interaction in the microcirculation during acute endothelial dysfunction, Faseb J, 14, 2357, 10.1096/fj.00-0183com Trovati, 2002, Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function, J Diabetes Complications, 16, 35, 10.1016/S1056-8727(01)00196-9 Vish, 2007, Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice, Crit Care Med, 35, 1348, 10.1097/01.CCM.0000260245.61343.B3 Wahren, 2004, C-peptide: new findings and therapeutic implications in diabetes, Clin Physiol Funct Imaging, 24, 180, 10.1111/j.1475-097X.2004.00558.x Wahren, 2000, Role of C-peptide in human physiology, Am J Physiol Endocrinol Metab, 278, E759, 10.1152/ajpendo.2000.278.5.E759 Walcher, 2004, C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and PI 3-kinase, Diabetes, 53, 1664, 10.2337/diabetes.53.7.1664 Walcher, 2006, C-peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2, Circ Res, 99, 1181, 10.1161/01.RES.0000251231.16993.88